JYNT vs. ACTG, APPS, REFR, XELB, RMCO, VHC, TIVO, FRG, DLB, and IDCC
Should you be buying Joint stock or one of its competitors? The main competitors of Joint include Acacia Research (ACTG), Digital Turbine (APPS), Research Frontiers (REFR), Xcel Brands (XELB), Royalty Management (RMCO), VirnetX (VHC), TiVo (TIVO), Franchise Group (FRG), Dolby Laboratories (DLB), and InterDigital (IDCC).
Joint (NASDAQ:JYNT) and Acacia Research (NASDAQ:ACTG) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk, profitability and community ranking.
Acacia Research has a net margin of 40.89% compared to Joint's net margin of -9.24%. Acacia Research's return on equity of 13.02% beat Joint's return on equity.
Joint currently has a consensus price target of $22.00, indicating a potential upside of 46.57%. Acacia Research has a consensus price target of $7.00, indicating a potential upside of 25.45%. Given Joint's higher probable upside, equities analysts clearly believe Joint is more favorable than Acacia Research.
In the previous week, Joint and Joint both had 3 articles in the media. Joint's average media sentiment score of 1.30 beat Acacia Research's score of 1.14 indicating that Joint is being referred to more favorably in the media.
Acacia Research received 2 more outperform votes than Joint when rated by MarketBeat users. However, 62.50% of users gave Joint an outperform vote while only 61.04% of users gave Acacia Research an outperform vote.
Joint has a beta of 1.58, indicating that its stock price is 58% more volatile than the S&P 500. Comparatively, Acacia Research has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500.
Acacia Research has higher revenue and earnings than Joint. Joint is trading at a lower price-to-earnings ratio than Acacia Research, indicating that it is currently the more affordable of the two stocks.
76.9% of Joint shares are owned by institutional investors. Comparatively, 86.7% of Acacia Research shares are owned by institutional investors. 30.2% of Joint shares are owned by company insiders. Comparatively, 1.7% of Acacia Research shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Acacia Research beats Joint on 11 of the 17 factors compared between the two stocks.
Get Joint News Delivered to You Automatically
Sign up to receive the latest news and ratings for JYNT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding JYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
